BackOrion Biotech Opportunities Overview

Orion Biotech Opportunities Long Term Debt

Latest long-term debt for ORIA: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Orion Biotech Opportunities Long Term Debt History

Loading

Orion Biotech Opportunities vs. peers: Long Term Debt Comparison

Loading

Orion Biotech Opportunities Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orion Biotech Opportunities (ORIA) FAQ

Orion Biotech Opportunities (ORIA) currently reports a long-term debt of $0 as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Orion Biotech Opportunities's long-term debt history and peer comparisons.

Orion Biotech Opportunities's long-term debt changed from $0 to $0 (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orion Biotech Opportunities reported $0 in long-term debt as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.